Hong Kong vs Montenegro: Lung cancer death rates
Hong Kong
15.53 deaths per 100,000 people
in 2017
Montenegro
14.26 deaths per 100,000 people
in 2019
Hong Kong rank
19th
Montenegro rank
21st
Lung cancer death rates over time
- Hong Kong
- Montenegro
How they compare
Hong Kong currently reports 15.53 deaths per 100,000 people against 14.26 deaths per 100,000 people in Montenegro, a difference of 1.27 deaths per 100,000 people.
That makes Hong Kong's figure about 1.1 times Montenegro's.
Across all 11 years both countries report, Hong Kong has been ahead every year.
Hong Kong ranks 19th and Montenegro ranks 21st of 111 countries.
Hong Kong has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Hong Kong | Montenegro | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.44 deaths per 100,000 people | 15.04 deaths per 100,000 people | 5.4 deaths per 100,000 people | Hong Kong |
| 2010s | 15.53 deaths per 100,000 people | 15.19 deaths per 100,000 people | 0.3391 deaths per 100,000 people | Hong Kong |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher lung cancer death rates, Hong Kong or Montenegro?
- Hong Kong, at 15.53 deaths per 100,000 people against 14.26 deaths per 100,000 people in Montenegro as of 2017.
- What is the difference in lung cancer death rates between Hong Kong and Montenegro?
- 1.27 deaths per 100,000 people, with Hong Kong ahead.
- How many years of comparable data are there for Hong Kong and Montenegro?
- 11 years are reported by both, from 2000 to 2017.
- How do Hong Kong and Montenegro rank globally for lung cancer death rates?
- Hong Kong ranks 19th and Montenegro ranks 21st of 111 countries.
- Where does this data come from?
- WHO Mortality Database (2025) – with minor processing by Our World in Data, published as Lung cancer death rates. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported deaths from trachea, bronchus, lung cancers in females in those aged all ages per 100,000 people.